WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'4301 Infant (under 12 months) mortality rate: 192
GDP / capita (US$): 7'9481 Child (under 5 years) mortality rate: 222

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 881  875  868  861  852  812  728  635 
Births 18  18  18  19  19  20  21  22 
Surviving infants 18  18  18  18  18  20  21  21 
Pop. less than 5 years 90  91  91  90  90  99  100  92 
Pop. less than 15 years 254  253  252  250  251  285  280  249 
Female 15-49 years 225  225  226  226  224  208  184  161 

Number of reported case

(Click for retrospective incidence data for Fiji)
Diphtheria
Japanese encephalitis
Measles 32  913 
Mumps
Pertussis 13 
Polio*
Rubella 25 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Fiji)
Vaccine year result method % card seen                                                
BCG 2007  100  EPI   78  99  100  61  99  88  100  95 
DTP1 2007  100  EPI   78  99  93  84  90  82 
DTP3 2007  99  EPI   78  98  91  84  87  75  82  68 
HepB_BD          99  100  61 
HepB3 2007  99  EPI   78  98  91  84  87  75 
Hib3 2007  99  EPI   78  98  91  84  87  75 
JapEnc         
MCV 2007  94  EPI   78  96  90  82  73  72  72  32 
MCV2          98  85  57 
PCV1          90 
PCV3          87 
Pol3 2007  99  EPI   78  98  91  84  86  76  87  55 
Rota1          90 
Rota_last          85 
Rubella1          96  90  82  73  72 
TT2plus          81  29 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Fiji)
BCG 99  99  99  99  99  96  99  95 
DTP1 99  99  99  99  99  97  98  87 
DTP3 99  99  99  99  99  90  97  68 
HepB3 99  99  99  99  99  98 
HepB_BD 90  90  90  90  90 
Hib3 99  99  99  99  99  98 
MCV 94  94  94  94  94  81  84  32 
MCV2 94  94  94  94  94 
PAB 94  94  94  94  94  84 
PnC3 87 
Pol3 99  99  99  99  99  91  96  55 
Rota_last 85 

Number of districts in the country 19  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 1st contact; +1, +6 months; Yes
HepB birth; Yes
MR 12 months; 6 years; Yes
OPV 6, 10, 14 weeks; 18 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 14 weeks; Yes
TT 6, 12 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2015    2007-2011  2007-2011  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 19  19  19  19  19  19   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes    No       

System performance

Total Nº districts in country number 19  19  19  20  19  19  19 
Nº districts with DTP3 coverage >=80% number 19  17  16 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  85  84 
Nº districts with measles (MCV1) coverage >=95% number     10       
% of districts with MCV1 coverage >=95% From 0 to 100%     50       

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 56  100    100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.